Kristina Capiak on Anavex 2-73
COMMENT The protocol or trial design or entry criteria were never changed after trial approval by the ethics committee, with the exception of extending Part B from 26 to 52 weeks. The first input into clinicaltrials.gov was performed by a new CRO member, who was ...